# Chai Discovery Nabs $400M Series C as AI-designed Antibodies Reach Big Pharma

> **Platform:** [SPIDITS AI](https://spidits.com/) — Real-Time AI News & Market Intelligence  
> **Published:** 2026-07-14T15:40:31.000Z  
> **Category:** FUNDING  
> **Impact Score:** 170/100  
> **Primary Source:** [SiliconANGLE](https://siliconangle.com/2026/07/14/chai-discovery-nabs-400m-series-c-ai-designed-antibodies-reach-big-pharma)  
> **Canonical Citation:** [https://spidits.com/timeline/chai-discovery-nabs-400m-series-c-as-ai-designed-antibodies-reach-big](https://spidits.com/timeline/chai-discovery-nabs-400m-series-c-as-ai-designed-antibodies-reach-big)

## Executive Summary
Chai Discovery Inc., a company that develops artificial intelligence models to predict interactions between biochemical molecules, today announced it has raised $400 million in Series C funding, nearly tripling its valuation to $3.8 billion.

## Why It Matters (Strategic Analysis)
Crucially, this shifts the paradigm in drug discovery, enabling precision, speed, and scale, as AI models like Chai-3 double success rates for molecular interaction targets.

## Referenced Coverage & Sources
- **[SiliconANGLE](https://siliconangle.com/2026/07/14/chai-discovery-nabs-400m-series-c-ai-designed-antibodies-reach-big-pharma)**: Chai Discovery nabs $400M Series C as AI-designed antibodies reach Big Pharma — _Chai Discovery Inc., a company that develops artificial intelligence models to predict interactions between biochemical molecules, today announced it has raised $400 million in new funding, nearly tripling its valuation to $3.8 billion. Index Ventures led the Series C round alongside Kleiner..._

---
*Synthesized by SPIDITS AI Market Intelligence Desk. Track live AI news, model releases, and funding: [https://spidits.com](https://spidits.com)*